The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
Open accessAbstract
Objective: To provide evidence‐based recommendations and expert guidance for the management of antineutrophil cytoplasmic antibody–associated vasculitis (AAV), including granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and eosinophilic granulomatosis with polyangiitis (EGPA). Methods: Clinical questions regarding the treatment and management of AAV were developed in the population, intervention, comparator, and outcome (PICO) format (47 for GPA/MPA, 34 for EGPA). Systematic literature reviews were conducted for each PICO question. The Grading of Recommendations Assessment, Development and Evaluation methodology was used to assess the quality of evidence and formulate recommendations. Each recommendation required ≥70% consensus among the Voting Panel. Results: We present 26 recommendations and 5 ungraded position statements for GPA/MPA, and 15 recommendations and 5 ungraded position statements for EGPA. This guideline provides recommendations for remission induction and maintenance therapy as well as adjunctive treatment strategies in GPA, MPA, and EGPA. These recommendations include the use of rituximab for remission induction and maintenance in severe GPA and MPA and the use of mepolizumab in nonsevere EGPA. All recommendations are conditional due in part to the lack of multiple randomized controlled trials and/or low‐quality evidence supporting the recommendations. Conclusion: This guideline presents the first recommendations endorsed by the American College of Rheumatology and the Vasculitis Foundation for the management of AAV and provides guidance to health care professionals on how to treat these diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Avacopan for the Treatment of ANCA-Associated Vasculitis
Jayne, D. R. W., Merkel, P. A., Schall, T. J., & Bekker, P. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2023386 · Cited by 1,021
Self-citationRetractedGRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Self-citationRituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
Stone, J. H., Merkel, P. A., Spiera, R., Seo, P., Langford, C. A., Hoffman, G. S., Kallenberg, C. G. M., St. Clair, E. W., Turkiewicz, A., Tchao, N. K., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909905 · Cited by 2,762
Self-citationMepolizumab Treatment in Patients with Severe Eosinophilic Asthma
Ortega, H. G., Liu, M. C., Pavord, I. D., Brusselle, G. G., FitzGerald, J. M., Chetta, A., Humbert, M., Katz, L. E., Keene, O. N., Yancey, S. W., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1403290 · Cited by 2,322
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
Jones, R. B., Cohen Tervaert, J. W., Hauser, T., Luqmani, R., Morgan, M. D., Peh, C. A., Savage, C. O., Segelmark, M., Tesar, V., van Paassen, P., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909169 · Cited by 1,748
Andrews, J., Guyatt, G., Oxman, A. D., Alderson, P., Dahm, P., Falck-Ytter, Y., Nasser, M., Meerpohl, J., Post, P. N., Kunz, R., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.03.013 · Cited by 1,416
Self-citationJayne, D. R. W., Gaskin, G., Rasmussen, N., Abramowicz, D., Ferrario, F., Guillevin, L., Mirapeix, E., Savage, C. O. S., Sinico, R. A., Stegeman, C. A., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007010090 · Cited by 1,125
Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis
Wechsler, M. E., Akuthota, P., Jayne, D., Khoury, P., Klion, A., Langford, C. A., Merkel, P. A., Moosig, F., Specks, U., Cid, M. C., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1702079 · Cited by 1,094
Self-citationRituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis
Guillevin, L., Pagnoux, C., Karras, A., Khouatra, C., Aumaître, O., Cohen, P., Maurier, F., Decaux, O., Ninet, J., Gobert, P., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1404231 · Cited by 1,090
Guillevin, L., Lhote, F., Gayraud, M., Cohen, P., Jarrousse, B., Lortholary, O., Thibult, N., & Casassus, P. (1996) · Medicine · doi:10.1097/00005792-199601000-00003 · Cited by 1,000
de Groot, K., Harper, L., Jayne, D. R. W., Flores Suarez, L. F., Gregorini, G., Gross, W. L., Luqmani, R., Pusey, C. D., Rasmussen, N., Sinico, R. A., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-10-200905190-00004 · Cited by 957
Guillevin, L., Pagnoux, C., Seror, R., Mahr, A., Mouthon, L., & Toumelin, P. L. (2011) · Medicine · doi:10.1097/md.0b013e318205a4c6 · Cited by 951
Comarmond, C., Pagnoux, C., Khellaf, M., Cordier, J., Hamidou, M., Viallard, J., Maurier, F., Jouneau, S., Bienvenu, B., Puéchal, X., et al. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37721 · Cited by 937
Giant-cell Granuloma of the Respiratory Tract (Wegener's Granulomatosis)
Walton, E. W. (1958) · BMJ · doi:10.1136/bmj.2.5091.265 · Cited by 930
Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis
Walsh, M., Merkel, P. A., Peh, C.-A., Szpirt, W. M., Puéchal, X., Fujimoto, S., Hawley, C. M., Khalidi, N., Floßmann, O., Wald, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1803537 · Cited by 893
Self-citationDe Groot, K., Rasmussen, N., Bacon, P. A., Tervaert, J. W. C., Feighery, C., Gregorini, G., Gross, W. L., Luqmani, R., & Jayne, D. R. W. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21142 · Cited by 801
Stegeman, C. A., Cohen Tervaert, J. W., de Jong, P. E., & Kallenberg, C. G. M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607043350103 · Cited by 777
Azathioprine or Methotrexate Maintenance for ANCA-Associated Vasculitis
Dhawan, R. (2009) · Yearbook of Medicine · doi:10.1016/s0084-3873(09)79350-2 · Cited by 674
Hiemstra, T. F., Walsh, M., Mahr, A., Savage, C. O., de Groot, K., Harper, L., Hauser, T., Neumann, I., Tesar, V., Wissing, K.-M., et al. (2010) · JAMA · doi:10.1001/jama.2010.1658 · Cited by 596
Gayraud, M., Guillevin, L., Le Toumelin, P., Cohen, P., Lhote, F., Casassus, P., Jarrousse, B., & the French Vasculitis Study Group (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200103)44:3<666::aid-anr116>3.0.co;2-a · Cited by 553
Mahr, A., Guillevin, L., Poissonnet, M., & Aymé, S. (2004) · Arthritis Care & Research · doi:10.1002/art.20077 · Cited by 550
Harper, L., Morgan, M. D., Walsh, M., Hoglund, P., Westman, K., Flossmann, O., Tesar, V., Vanhille, P., Groot, K. D., Luqmani, R., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200477 · Cited by 432
Tomasson, G., Grayson, P. C., Mahr, A. D., LaValley, M., & Merkel, P. A. (2012) · Rheumatology · doi:10.1093/rheumatology/ker280 · Cited by 353
Self-citationMerkel, P. A., Lo, G. H., Holbrook, J. T., Tibbs, A. K., Allen, N. B., Davis, J. C., Hoffman, G. S., McCune, W. J., Clair, E. W. S., Specks, U., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-8-200504190-00010 · Cited by 312
Self-citationRituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg–Strauss)
Mohammad, A. J., Hot, A., Arndt, F., Moosig, F., Guerry, M.-J., Amudala, N., Smith, R., Sivasothy, P., Guillevin, L., Merkel, P. A., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206095 · Cited by 268
Self-citationWalsh, M., Casian, A., Flossmann, O., Westman, K., Höglund, P., Pusey, C., & Jayne, D. R. W. (2013) · Kidney International · doi:10.1038/ki.2013.131 · Cited by 264
Smith, R. M., Jones, R. B., Guerry, M., Laurino, S., Catapano, F., Chaudhry, A., Smith, K. G. C., & Jayne, D. R. W. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34583 · Cited by 250 · cited 1×
“Different doses of rituximab have been used for remission maintenance, including IV 500 mg every 6 months (18) (FDAapproved), IV 1,000 mg every 4 months (20), and IV 1,000 mg every 6 months (21).”
Metzler, C., Miehle, N., Manger, K., Iking-Konert, C., de Groot, K., Hellmich, B., Gross, W. L., Reinhold-Keller, E., & for the German Network of Rheumatic Diseases (2007) · Rheumatology · doi:10.1093/rheumatology/kem029 · Cited by 220
Karras, A., Pagnoux, C., Haubitz, M., Groot, K. D., Puechal, X., Tervaert, J. W. C., Segelmark, M., Guillevin, L., & Jayne, D. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-211123 · Cited by 211
Venous thromboembolism in ANCA-associated vasculitis--incidence and risk factors
Stassen, P. M., Derks, R. P. H., Kallenberg, C. G. M., & Stegeman, C. A. (2007) · Rheumatology · doi:10.1093/rheumatology/ken035 · Cited by 207
de Groot, K., Reinhold‐Keller, E., Tatsis, E., Paulsen, J., Heller, M., Nölle, B., & Gross, W. L. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780391215 · Cited by 185
What is known about the epidemiology of the vasculitides?
Watts, R. A., Lane, S., & Scott, D. G. I. (2005) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2004.11.006 · Cited by 178 · cited 3×
“The overall prevalence of EGPA in European populations has been estimated to range from 2 to 38 cases per million (1,3).”
Neumann, I., Santesso, N., Akl, E. A., Rind, D. M., Vandvik, P. O., Alonso-Coello, P., Agoritsas, T., Mustafa, R. A., Alexander, P. E., Schünemann, H., et al. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2015.11.017 · Cited by 177
Self-citationPuéchal, X., Pagnoux, C., Baron, G., Quémeneur, T., Néel, A., Agard, C., Lifermann, F., Liozon, E., Ruivard, M., Godmer, P., et al. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40205 · Cited by 169
Durel, C., Berthiller, J., Caboni, S., Jayne, D., Ninet, J., & Hot, A. (2016) · Arthritis Care & Research · doi:10.1002/acr.22686 · Cited by 158
Hauser, T., Mahr, A., Metzler, C., Coste, J., Sommerstein, R., Gross, W. L., Guillevin, L., & Hellmich, B. (2008) · Thorax · doi:10.1136/thx.2007.087825 · Cited by 143
Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis
Teixeira, V. S., Mohammad, A. J., Jones, R. B., Smith, R., & Jayne, D. R. W. (2019) · RMD Open · doi:10.1136/rmdopen-2019-000905 · Cited by 102
Maritati, F., Alberici, F., Oliva, E., Urban, M. L., Palmisano, A., Santarsia, F., Andrulli, S., Pavone, L., Pesci, A., Grasselli, C., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185880 · Cited by 87
Alexander, P. E., Gionfriddo, M. R., Li, S., Bero, L. A., Stoltzfus, R. J., Neumann, I., Brito, J. P., Djulbegović, B., Montori, V. M., Norris, S. L., et al. (2015) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2015.09.006 · Cited by 63
Self-citationLong-term Outcomes of Rituximab Therapy in Ocular Granulomatosis with Polyangiitis
Joshi, L., Tanna, A., McAdoo, S. P., Medjeral‐Thomas, N., Taylor, S. R. J., Sandhu, G., Tarzi, R. M., Pusey, C. D., & Lightman, S. (2015) · Ophthalmology · doi:10.1016/j.ophtha.2015.01.016 · Cited by 58
Congdon, D. J., Sherris, D. A., Specks, U., et al. (2002) · The Laryngoscope · doi:10.1097/00005537-200204000-00025 · Cited by 56
Kado, R., Sanders, G., & McCune, W. J. (2017) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000377 · Cited by 44
Thromboembolism—Another Threat to the Polymorbid Patient with Vasculitis?
Merkel, P. A., Lo, G. K., Holbrook, J. H., Tibbs, A. K., Nb, A., Davis, J. C., Hoffman, G. S., McCune, W. J., Clair, E. W. S., Specks, U., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005050528 · Cited by 30
Self-citationNasal surgery in patients with systemic disorders
Sachse, F., & Stoll, W. (2010) · PubMed Central · doi:10.3205/cto000066 · Cited by 15
Cited by
EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update
Hellmich, B., Sanchez-Alamo, B., Schirmer, J. H., Berti, A., Blockmans, D., Cid, M. C., Holle, J. U., Hollinger, N., Karadag, O., Kronbichler, A., et al. (2024) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2022-223764 · Cited by 768
Self-citationConnelly‐Smith, L., Alquist, C. R., Aqui, N. A., Hofmann, J. C., Klingel, R., Onwuemene, O. A., Patriquin, C. J., Pham, H. P., Sanchez, A. P., Schneiderman, J., et al. (2023) · Journal of Clinical Apheresis · doi:10.1002/jca.22043 · Cited by 684
Emmi, G., Bettiol, A., Gelain, E., Bajema, I. M., Berti, A., Burns, S., Cid, M. C., Cohen Tervaert, J. W., Cottin, V., Durante, E., et al. (2023) · Nature Reviews Rheumatology · doi:10.1038/s41584-023-00958-w · Cited by 334
Maher, T. M., Tudor, V. A., Saunders, P., Gibbons, M. A., Fletcher, S. V., Denton, C. P., Hoyles, R. K., Parfrey, H., Renzoni, E. A., Kokosi, M., et al. (2023) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(22)00359-9 · Cited by 290
Metadata
- Authors
- Chung, S. A., Langford, C. A., Maz, M., Abril, A., Gorelik, M., Guyatt, G., Archer, A. M., Conn, D. L., Full, K. A., Grayson, P. C., Ibarra, M. F., Imundo, L. F., Kim, S., Merkel, P. A., Rhee, R. L., Seo, P., Stone, J. H., Sule, S., Sundel, R. P., Vitobaldi, O. I., Warner, A., Byram, K., Dua, A. B., Husainat, N., James, K. E., Kalot, M. A., Lin, Y. C., Springer, J. M., Turgunbaev, M., Villa‐Forte, A., Turner, A. S., & Mustafa, R. A.
- Venue
- Arthritis & Rheumatology
- Publisher
- Wiley
- Published
- 2021-07-08
- Volume
- 73
- Issue
- 8
- Pages
- 1366-1383
- ISSN
- 2326-5191 (ISSN-L)
- 2326-5205
- OpenAlex
- W3181405838
- Cited by
- 702
- References
- 44
- FWCI
- 62.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.